Navigation Links
Plavix, Heartburn Drug Safe to Take Together: Study
Date:9/21/2010

By Steven Reinberg
HealthDay Reporter

TUESDAY, Sept. 21 (HealthDay News) -- A new study finds it's safe to take the blood thinner Plavix with proton-pump inhibitors like Nexium, contrary to recent research that said the combination compromised Plavix's effectiveness.

"We looked into this highly debated area of clopidogrel [Plavix] and proton-pump inhibitors," said lead researcher Dr. Mette Charlot from the department of cardiology at Copenhagen University Hospital Gentofte in Hellerup, Denmark. "We did not find any evidence of drug interaction."

Proton-pump inhibitors are heartburn drugs. Doctors often prescribe the two drugs in combination to prevent clotting and reduce the risk of stomach bleeding, which can be a serious complication for patients taking Plavix, the researchers said.

This study is larger than studies that found an interaction between the drugs, and this data included patients who were taking PPIs but not Plavix, Charlot noted.

"What we actually found was an increased risk related to the use of proton-pump inhibitors, but we found the risk was the same in patients treated with clopidogrel and patients not treated with clopidogrel," Charlot said.

For the study, published in the Sept. 21 issue of the Annals of Internal Medicine and funded by the Danish Medical Research Council and the Danish Heart Foundation, Charlot's team collected outcome data on 56,406 patients across Denmark who had a first heart attack between 2000 and 2006. Follow-up was one year.

Sixteen percent were rehospitalized for a heart attack or stroke, or died. Of the 44 percent of patients who took Plavix, 27 percent also took a PPI, the researchers say.

Patients taking both medications had a 29 percent increased risk of rehospitalization for a heart attack or stroke, or death. However, among patients taking only a PPI, the risk of these adverse events was also 29 percent, the researchers found.

The researchers concluded that the increased risk of a heart attack, stroke or death is associated with PPIs, and not the combination of Plavix and a PPI.

"We are confident that the feared interaction between the two drugs does not happen," Charlot said. "We believe that patients who have an indication for PPI treatment should definitely be treated with PPIs to avoid the risk of gastrointestinal bleeding," she added.

Dr. James Brophy, a professor of medicine and epidemiology at the Royal Victoria Hospital in Montreal, Canada, said this new research carries more weight than the earlier studies.

This study "appears to be of superior quality to several previous reports," said Brophy, author of an accompanying journal editorial. "There is not high quality evidence supporting a meaningful drug interaction between clopidogrel and PPIs," he said.

"While unnecessary drug prescribing is always to be avoided, the current evidence suggests that patients taking clopidogrel can take a PPI," Brophy said.

Additional studies would be helpful, Brophy added, "but in the interim, the dangers of bleeding from avoiding PPIs may well be greater than any cardiac risks from inhibiting clopidogrel."

More information

For more information on the Plavix-PPI combo, visit the U.S. Food and Drug Administration.

SOURCES: Mette Charlot, M.D., department of cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark; James Brophy, M.D., Ph.D., professor, medicine and epidemiology, Royal Victoria Hospital, Montreal; Sept. 21, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Warns of Fracture Risk With Popular Heartburn Drugs
2. Coming Soon: A Low-Heartburn Coffee?
3. A century-old puzzle comes together: Scientists ID potential protein trigger in lung disease sarcoidosis
4. Study Claims Flu Shots Associated With Lower Risk of Heart Attack
5. Investigational eye treatment: Corneal collagen crosslinking research study
6. For Common Warts, Freezing Therapy Works Best: Study
7. Study: How Palestinian and Israeli children are psychologically scarred by exposure to war
8. Study: Mental illness stigma entrenched in American culture; new strategies needed
9. Successful periodontal therapy may reduce the risk of preterm birth, according to Penn dental study
10. New study finds positive return on investment for states that invest in quit smoking treatments
11. In Vitro Fertilization Success Rate Higher in Spring, Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plavix, Heartburn Drug Safe to Take Together: Study
(Date:7/27/2017)... ... July 27, 2017 , ... ... from 2012-2016, will keynote Day 2 of the HIMSS Healthcare Security Forum, the ... at the Sheraton Boston Hotel, Sept. 11-13, 2017. , Daniel will deliver his ...
(Date:7/26/2017)... ... July 26, 2017 , ... Capillus, LLC has announced ... hair loss. The new Flexible Fitting Design offers a more comfortable, adaptable fit and ... delighted with the improvements to the home-use laser therapy caps intended to improve both ...
(Date:7/26/2017)... , ... July 26, 2017 , ... Six greater Bay Area roller derby leagues are ... ‘em Bleed,” the most widely attended series of blood drives in California, beginning July 29. ... over the past 4 years -- enough to have helped to save up to 2700 ...
(Date:7/26/2017)... , ... July 26, 2017 , ... A major challenge ... Inconsistent results freeze drying samples and a lengthy freeze dry cycle are a few ... discuss freeze drying techniques, as well as new accessories and advancements in laboratory freeze ...
(Date:7/26/2017)... ... 2017 , ... “We are dentists and we thought there could be an ... we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending MAGNETIC/ LOCK BRACKETS provides an ... it offers an effective alternative to traditional braces. As a result, it enhances comfort ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants totaling ... as part of its prestigious Bayer Hemophilia Awards Program (BHAP). ... Philadelphia and Uniformed Services University of ... among the winners. Grant recipients were announced last night during ... (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... of Echenberg Institute, is announcing a new safe and effective at-home VuVa ... other painful pelvic pain conditions such as pelvic floor dysfunction, vulvodynia, vulvar ... ... VuVa ... company, VuVatech LLC, fills a void in the women,s wellness market because ...
(Date:7/10/2017)... 2017 The Institute for In Vitro Sciences ... recipient of a VITROCELL® inhalation exposure system thanks to ... The device, which is designed to replace animals in ... cells to airborne test materials in an environment that ... system for testing combustible tobacco products, as well as ...
Breaking Medicine Technology: